Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Analysis in 2 Large, Prospectively Evaluated Cohorts.
Johannes CampLina GlaubitzTim FillaAchim J KaaschFrieder FuchsMatt ScarboroughHong Bin KimRobert TilleyChun-Hsing LiaoJonathan EdgeworthEmmanuel NsutebuLuis Eduardo López-CortésLaura MorataMartin J LlewelynVance G FowlerGuy ThwaitesHarald SeifertWinfried V KernOliver KussSiegbert RiegPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Immunosuppressive agents were not associated with an overall higher mortality. The risk for SAB-related late complications in patients receiving specific immunosuppressive agents such as IMOTS warrants further investigations.